FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Nova Max Creat eGFR Monitoring System

K Number: K251281 · Decision Jan 21, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0
Same Product Code
0
Applicant Total
40
Review Days
272

Basic Information

Device Name
Nova Max Creat eGFR Monitoring System
K Number
K251281
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.1225
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Nova Biomedical Corporation
Date Received
April 24, 2025
Decision Date
January 21, 2026
Product Code
SHB
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
SHB Creatinine Test System For At Home Prescription Use

Other Clearances by Nova Biomedical Corporation

K Number Device Name
K252206 Nova Allegro UACR Assay, Nova Allegro Analyzer
K221326 Nova Allegro HbA1c Assay, Nova Allegro Analyzer
K221813 Nova Allegro UACR Assay, Nova Allegro Analyzer
K232075 StatStrip Glucose Hospital Meter System
K221900 Stat Profile Prime Plus Analyzer System
K203549 Nova Primary Glucose Analyzer System
K200403 Stat Profile Prime Plus Analyzer System
K200204 Stat Profile Prime Plus Analyzer System
K200349 Stat Profile Prime Plus Analyzer System
K193246 Stat Profile Prime Plus Analyzer System
Search all 40 clearances from Nova Biomedical Corporation →